Skip to main content Skip to search Skip to main navigation

What is confirmed by the written confirmation for imported APIs?

The written confirmation confirms the following:
• The GMP standards applicable to the third-country active substance manufacturer are at least equivalent to those laid down by the European Union.
• The manufacturing plant in the third country is subject to regular, strict and transparent controls and to repeated and unannounced inspections, so as to ensure the effective implementation of GMP standards by the competent authority in the third country and to assure supervision by the competent authority that is at least equivalent to EU requirements.
• Any reports of non-compliance shall be communicated to the European Union without delay.

[GMP Compliance Adviser, Chapter 20.B]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

What are the quality requirements for pharmaceutical gases?

What are the quality requirements for pharmaceutical gases?

You can view the answer here:
Read more
EMA: Update on the Guideline “Stability Testing for Variations”

EMA: Update on the Guideline “Stability Testing for Variations”

The EMA has updated the guideline on stability testing for variations (Revision 3, applicable from 15 January 2026).
Read more
EU: Proposal for Simplification of Medical Device Rules

EU: Proposal for Simplification of Medical Device Rules

The European Commission has proposed targeted reforms to simplify the Medical Device Regulation (Regulation (EU) 2017/745, MDR) and the In Vitro Diagnostic Regulation (Regulation (EU) 2017/746, IVDR) and to address structural implementation challenges.
Read more
Previous
Next